SANOFI CONSUMER HEALTHCARE INDIA Financial Statement Analysis
|
||
The Revenues of SANOFI CONSUMER HEALTHCARE INDIA have increased by 30.45% YoY .
The Earnings Per Share (EPS) of SANOFI CONSUMER HEALTHCARE INDIA has decreased by -90.45 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SANOFI CONSUMER HEALTHCARE INDIA Last 5 Annual Financial Results
[BOM: 544250|NSE : SANOFICONR]
Standalone | Dec2024 | Dec2023 |
---|---|---|
Revenues | ₹725 Cr | ₹555 Cr |
Expenses | ₹454 Cr | ₹337 Cr |
Operating Profit (Excl OI) | ₹271 Cr | ₹219 Cr |
Other Income | ₹13 Cr | ₹4.10 Cr |
Interest | ₹3.90 Cr | ₹0.00 Cr |
Depreciation | ₹4.50 Cr | ₹1.80 Cr |
Profit Before Tax | ₹247 Cr | ₹219 Cr |
Profit After Tax | ₹181 Cr | ₹165 Cr |
Earnings Per Share (Rs) | ₹78.70 | ₹824.50 |
PAT Margin (%) | 23.92 | 28.54 |
ROE(%) | 79.28 | 89.33 |
ROCE(%) | 104.33 | 105.64 |
Total Debt/Equity(x) | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 11,914.2 Cr |
Revenue (TTM) | : | ₹ 724.1 Cr |
Net Profit(TTM) | : | ₹ 200.0 Cr |
EPS (TTM) | : | ₹ 87.0 |
P/E (TTM) | : | 59.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
SANOFI CONSUMER HEALTHCARE INDIA | 0.5% | 4% | NA |
SUN PHARMACEUTICAL INDUSTRIES | -3% | -6.8% | -11.3% |
DIVIS LABORATORIES | -0.5% | -8.4% | 25.1% |
CIPLA | -0.2% | 1% | -1.2% |
TORRENT PHARMACEUTICALS | -3.4% | -5.6% | 6.3% |
DR REDDYS LABORATORIES | -1.1% | -2.9% | -9.5% |
MANKIND PHARMA | -5.2% | -3.2% | 1.9% |
ZYDUS LIFESCIENCES | -0.8% | -1.4% | -12.3% |
LUPIN | -4.2% | -4.6% | -12.4% |
SANOFI CONSUMER HEALTHCARE INDIA Revenues
[BOM: 544250|NSE : SANOFICONR]
Y-o-Y | 30.45 % |
5 Yr CAGR | 30.45 % |
Years | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹725 Cr | 30.45 | |
Dec2023 | ₹555 Cr | - |
SANOFI CONSUMER HEALTHCARE INDIA Operating Profit
[BOM: 544250|NSE : SANOFICONR]
Y-o-Y | 23.67 % |
5 Yr CAGR | 23.67 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹271 Cr | 23.67 | |
Dec2023 | ₹219 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -5.20 % |
5 Yr CAGR | -5.20 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 37.35% | -5.20 | |
Dec2023 | 39.4% | - |
SANOFI CONSUMER HEALTHCARE INDIA Profit After Tax
[BOM: 544250|NSE : SANOFICONR]
Y-o-Y | 9.76 % |
5 Yr CAGR | 9.76 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹181 Cr | 9.76 | |
Dec2023 | ₹165 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -16.19 % |
5 Yr CAGR | -16.19 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 23.92 % | -16.19 | |
Dec2023 | 28.54 % | - |
SANOFI CONSUMER HEALTHCARE INDIA Earnings Per Share (EPS)
[BOM: 544250|NSE : SANOFICONR]
Y-o-Y | -90.45 % |
5 Yr CAGR | -90.45 % |
Years | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹79 | -90.45 | |
Dec2023 | ₹825 | - |
SANOFI CONSUMER HEALTHCARE INDIA Return on Capital Employed (ROCE)
[BOM: 544250|NSE : SANOFICONR]
Y-o-Y | -1.24 % |
5 Yr CAGR | -1.24 % |
Years | ROCE | % Change | |
---|---|---|---|
Dec2024 | 104.33% | -1.24 | |
Dec2023 | 105.64% | - |
SANOFI CONSUMER HEALTHCARE INDIA Share Price vs Sensex
Current Share Price | : | ₹5,180.1 |
Current MarketCap | : | ₹ 11,914.2 Cr |
Updated EOD on | : | Aug 29,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SANOFI CONSUMER HEALTHCARE INDIA | 0.5% |
4% |
|
SENSEX | -2.7% |
-1.3% |
-2.3% |
SANOFI CONSUMER HEALTHCARE INDIA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | -2.6% | -3.7% | 3.5% |
BSE SMALLCAP | -3.3% | -3.3% | -7.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY TOTAL MARKET | -2.9% | -1.7% | -4.8% |
NIFTY MICROCAP 250 | -3.3% | -2.9% | -8.3% |
You may also like the below Video Courses
FAQ about SANOFI CONSUMER HEALTHCARE INDIA Financials
How the annual revenues of SANOFI CONSUMER HEALTHCARE INDIA have changed ?
The Revenues of SANOFI CONSUMER HEALTHCARE INDIA have increased by 30.45% YoY .
How the Earnings per Share (EPS) of SANOFI CONSUMER HEALTHCARE INDIA have changed?
The Earnings Per Share (EPS) of SANOFI CONSUMER HEALTHCARE INDIA has decreased by -90.45 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs